NewsRoom Articles - Page 190 of 226

FridayJan 29, 2021 12:13 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

Torrey Hills Capital is a leading investor and financial public relations firm that offers extensive expertise in investor relations, corporate communications and other market support operations The services provided to Imagin Medical will be overseen by Torrey Hills Founder and Principal Cliff Mastricola Imagin believes its proprietary imaging technology, the i/Blue Imaging System(TM), will establish a new standard of care in visualizing cancer during minimally invasive procedures Company’s current focus is bladder cancer, the 6th most prevalent form of cancer and most expensive to treat Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has engaged the services of…

ThursdayJan 28, 2021 3:52 pm

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Flaws in the U.S. health-care system revealed during COVID-19 pandemic Lack of medication adherence can lead to serious issues, including worsening of disease, possible death and increased costs United Medical offers solutions for poor patient-physician communication and inadequate medication knowledge The COVID-19 pandemic has revealed flaws in the U.S. health-care system, including flaws that require patients and caregivers to take a more active and educated role. United Medical Equipment Business Solutions Network (“UME”) provides reliable resources and solutions to help providers work more proficiently, health-care systems work smarter, and patients live healthier lives. “This pandemic is a watershed moment in…

ThursdayJan 28, 2021 2:30 pm

Study Links Coronavirus to Life-Threatening Blood Clots Found in Lower Limbs

According to study results reported in “Radiology", researchers have discovered that the coronavirus is linked to fatal blood clots in leg arteries. The researchers stated that coronavirus patients who were in short supply of blood to their lower limbs tended to have bigger clots, and remarkably higher amputation rates and death, especially in comparison with COVID-negative individuals who had identical conditions. When the pandemic was at its peak in New York, radiologists from a medical center in the Bronx noted a rise in the number of patients who tested positive for lower extremity arterial thrombosis on CT angiography exams. The…

ThursdayJan 28, 2021 2:16 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

Ovarian cancer is a leading cause of death, causes more death than any other female reproductive system cancer POAI’s Helomics dedicated to improving clinical decision making for ovarian cancer patients Helomics has pioneered testing of drugs on patients’ own tumors to help oncologists individualize treatment options According to the American Cancer Society, an estimated 21,750 women received a new diagnosis of ovarian cancer this year, and almost 14,000 women will die from the disease (https://ibn.fm/4yfJn). Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women; ovarian cancer causes more deaths than any other cancer of the female reproductive…

WednesdayJan 27, 2021 3:46 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

Company will initiate a Phase II adult trial for Berubicin this year focused on patients with glioblastoma multiforme WPD, a CNS sub-license partner, will be commencing a parallel Phase II adult trial and the first-ever pediatric Berubicin trial Additional clinical trials are in the pipeline, including one for the company’s newest drug candidate, WP1244, and its effects on central nervous system tumors Biopharmaceutical company CNS Pharmaceuticals (NASDAQ: CNSP) recently took part in the H.C. Wainwright Bioconnect 2021 Virtual Conference, which took place January 11-14, 2021. CNS’s CEO John Climaco gave a presentation at the event, discussing how the clinical-stage biopharmaceutical…

WednesdayJan 27, 2021 3:00 pm

New Study Discovers Patient’s Immune System Continues Building Resistance After Recovering from COVID-19

The novel coronavirus has affected many countries, infecting roughly 96.2 million people across the globe. Of the 96 million individuals, about 53 million have recovered from this disease while nearly 2 million individuals have, sadly, succumbed to the deadly infection. Researchers have been trying to figure out how long the immunity of an individual who recovered from the disease will last. A recent study by Rockefeller University researchers provides an answer to this, suggesting that individuals who recover from the coronavirus are protected against the deadly infection for about six months, and likely much longer. The study’s findings provide strong…

TuesdayJan 26, 2021 2:46 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Research shows that market for agricultural biopesticides expected to grow rapidly at CAGR of 14.7% until 2025 MustGrow providing natural plant-based biopesticide solutions for protecting plants from pests and diseases, utilizing the natural defense mechanism of the mustard plant Company seems well positioned within biopesticides market expected to achieve fastest growth The market for agricultural biopesticides is growing rapidly. The latest Markets and Markets report estimated the industry was valued at $4.3 billion in 2020 and is projected to almost double its size in the next five years — reaching $8.5 billion by 2025 and growing at a CAGR of…

TuesdayJan 26, 2021 2:30 pm

Study Reveals Connection Between Mental Health Issues and Obesity in Adolescents

A new study by scientists from the University of Gothenburg in Sweden and Lund University, has discovered that many young people who are treated for severe obesity also possess neuropsychiatric issues. More than half of the teens from the study suffered from various mental health conditions, as reported by their parents or themselves. While the link between eating disorders, depression and ADHD has long been observed by researchers, not a lot of research that has been focused on the connection. However, the research that is available has shown that from the early 2000s, both mental illness and obesity have increased…

TuesdayJan 26, 2021 2:12 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

Imagin Medical Inc. successfully weathered the 2020 pandemic-induced economic challenges and transitioned its surgical visualization product, the i/Blue Imaging System(TM) from the development stage to manufacturing and has after Imagin’s next stage will be supported by a $3 million convertible note, with the final funding tranche expected to close this quarter The i/Blue Imaging System combines the advantages of blue light with advanced optic and light sensors to address the limitations of both white and blue light imaging to help surgeons better visualize and remove cancerous cells. The system uses a contrast agent to highlight the cancer and projects both…

MondayJan 25, 2021 1:14 pm

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

UME commited to offering high-quality COVID-19 services, solutions and supplies. To effectively end worldwide pandemic, systematic screening and detection of both clinical and asumptomatic COVID-19 tests is critical. CareStart antigen test features 10-minute processing time, identifies acute infection, helps provide critical answers. Despite approval and rollout of COVID-19 vaccines, experts agree that even as the pandemic dies down in the coming months, SARS-CoV-2, the virus that causes the infectious disease, is likely here for the long haul (https://ibn.fm/1idh8). United Medical Equipment Business Solutions Network ("UME") is here for the long haul too, commited to offering high-quality COVID-19 services, solutions and supplies.…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Contracts Torrey Hills Capital to Boost Awareness of Its Proprietary Cancer Visualization Technology

United Medical Equipment Business Solutions Network Inc. Breaks Barriers to Medication Adherence

Study Links Coronavirus to Life-Threatening Blood Clots Found in Lower Limbs

Predictive Oncology (NASDAQ: POAI) Subsidiary Working to Individualize, Improve Ovarian Cancer Treatment Options

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Discusses Product Pipeline, Clinical Trial Plans, at H.C. Wainwright Bioconnect 2021 Virtual Conference

New Study Discovers Patient’s Immune System Continues Building Resistance After Recovering from COVID-19

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Well Placed as Agricultural Biopesticides Market Expected to Grow Rapidly

Study Reveals Connection Between Mental Health Issues and Obesity in Adolescents

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Enters 2021 with Optimism for Its Cancer Imaging Technology

United Medical Equipment Business Solutions Network Inc. Adds CareStart Antigen Test to List of COVID-19 Supplies

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search